Thumbnail Image
Item

COVID-19 Stem Cell Treatment Tested at UMB

Authors
Kotz, Deborah
Advisor
Date
2020-05-28
Embargo until
Language
Book title
Publisher
Peer Reviewed
Type
Article
Video
Research Area
Jurisdiction
Collections
UMB Response to Novel Coronavirus (COVID-19)
Show all metadata
Files
Thumbnail Image
COVID-19StemCellTreatment_2020.05.28.pdf
Adobe PDF, 296.52 KB
Other Titles
See at
https://youtu.be/ND6suElbZw4
Abstract
Data Availibility
Data / Code Location
Table of Contents
Description
News release announcing that researchers at the University of Maryland School of Medicine (UMSOM) have begun testing an experimental stem cell therapy developed by Mesoblast Limited to treat hospitalized COVID-19 patients with moderate to severe acute respiratory distress syndrome (ARDS) who are on ventilators to help them breathe. Additional information available via the accompanying video.
Citations
Altmetric:
Series/Report No.
Sponsors
Rights/Terms
Keyword
Coronavirus Disease 2019 (COVID-19)
 Mesoblast Limited
 remestemcel-L
 Stem Cell Research
 COVID-19
 University of Maryland, Baltimore
 University of Maryland Medical Center
 COVID-19 (Disease)
Identifier to cite or link to this item
http://hdl.handle.net/10713/12894
Scopus Identifier
Embedded videos